Publication | Closed Access

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

Il-15-activated Nk CellsBreast OncologyCancer ImmunosurveillanceBreast Cancer PatientsImmunologyImmune Checkpoint InhibitorBreast CancerTriple-negative Breast CancerImmunotherapyMedicineCell Biology